3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Thyroid Nodule
2
Pain
2
Carcinoma, Hepatocellular
2
Breast Neoplasms
2
Agnosia
2
Prostatic Neoplasms
1
Neuroma
1
Neuralgia
1
Neoplasm Metastasis
1
Myoma
1
Multiple Pulmonary Nodules
1
Multiple Advanced Tumors After PD-1 Therapy Failure
1
Menorrhagia
1
Lymphoma, Follicular
1
Lipoma
1
Leiomyoma
1
Hypesthesia
1
Hyperthyroidism
1
Hyperaldosteronism
1
Esophageal Neoplasms
1
Colorectal Neoplasms
1
Cicatrix
1
Carcinoma, Renal Cell
1
Breast Cancer Female
1
Bone Cancer Metastatic
1
Barrett Esophagus
1
Adenocarcinoma Of Esophagus
1
Adenocarcinoma
1
ACTH Syndrome, Ectopic
1
Interventions
Magnetic Resonance Spectroscopy
5
trametinib
4
Vemurafenib
4
selpercatinib
3
dabrafenib
3
Specimen Handling
3
entrectinib
2
cobimetinib
2
cabozantinib
2
X-Rays
2
Iodine-131
2
Interviews as Topic
2
tremelimumab
1
tovorafenib
1
spartalizumab
1
pembrolizumab
1
omipalisib
1
lenvatinib
1
gallium Ga 68 dotatate
1
durvalumab
1
copanlisib
1
Whole Body Imaging
1
Transurethral Resection of Prostate
1
Thyrotropin Alfa
1
Surveys and Questionnaires
1
Sodium Iodide
1
Robotic Surgical Procedures
1
Postoperative Period
1
Phantoms, Imaging
1
Nivolumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Thyroid Cancer, Papillary
×
Radiofrequency Ablation
×
1 year
×
Clear all
No trials found.